4.6 Article

Constipation in cancer patients on morphine

Journal

SUPPORTIVE CARE IN CANCER
Volume 16, Issue 5, Pages 453-459

Publisher

SPRINGER
DOI: 10.1007/s00520-007-0373-1

Keywords

constipation; laxatives; morphine; cancer; laxative dose groups

Ask authors/readers for more resources

Goals of work Constipation is a significant problem in patients taking morphine for cancer pain. The aims of this study were (1) to assess the magnitude of constipation in this study cohort, (2) to analyse the constipation treatment strategies and (3) to look for evidence of inter-individual variation in both susceptibility to constipation and response to treatment with laxatives in this patient group. Materials and methods This was an observational study carried out in a tertiary referral cancer hospital. Two hundred seventy four patients were recruited to the study. All had a diagnosis of cancer and were on oral morphine for cancer pain. The main outcomes measured were subjective patient assessment of constipation severity in the preceding week and laxative use. Patients were asked to grade constipation in the preceding week on a four-point categorical scale: not at all (grade 0), a little (grade 1), quite a bit (grade 2) and very much (grade 3). Laxative dose groups (LDGs) were developed to assess laxative dosing. Results Constipation affects 72% of this cohort of patients. Constipation in this population is poorly managed. Eighty nine percent of constipated patients were on inadequate laxative therapy. Inter-individual variation in constipation on morphine exists: some patients do not experience constipation and do not need to take any laxatives, some patients do not experience constipation because they are taking laxatives and some patients experience constipation despite being on high dose laxatives. These three groups were compared in terms of cancer diagnosis, time on morphine, dose of morphine and other concomitant factors. No factor was identified to account for this inter-individual variation. Improvement in the clinical management of constipation is needed, with titration of laxatives according to individual patient need. Conclusion Constipation affects a large proportion of cancer patients taking oral morphine. Constipation in these patients is generally inadequately treated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Health Care Sciences & Services

Advance care planning: the impact of Ceiling of Treatment plans in patients with Coordinate My Care

Helen Lucy Broadhurst, Joanne Droney, Tom Callender, Amanda Shaw, Julia Riley

BMJ SUPPORTIVE & PALLIATIVE CARE (2019)

Article Nursing

Burnout: Caring for critically ill and end-of-life patients with cancer

Natalie Pattison, Joanne Droney, Pascale Gruber

NURSING IN CRITICAL CARE (2020)

Article Medicine, Research & Experimental

Managing uncertain recovery for patients nearing the end of life in hospital: a mixed-methods feasibility cluster randomised controlled trial of the AMBER care bundle

J. Koffman, E. Yorganci, D. Yi, W. Gao, F. Murtagh, A. Pickles, S. Barclay, H. Johnson, R. Wilson, L. Sampson, J. Droney, M. Farquhar, T. Prevost, C. J. Evans

TRIALS (2019)

Review Oncology

Triggers for early palliative care referral in patients with cancer: a review of urgent unplanned admissions and outcomes

Rebecca Gemmell, Nadia Yousaf, Joanne Droney

SUPPORTIVE CARE IN CANCER (2020)

Article Multidisciplinary Sciences

Implementation of a complex intervention to improve care for patients whose situations are clinically uncertain in hospital settings: A multi-method study using normalisation process theory

Halle Johnson, Emel Yorganci, Catherine J. Evans, Stephen Barclay, Fliss E. M. Murtagh, Deokhee Yi, Wei Gao, Elizabeth L. Sampson, Joanne Droney, Morag Farquhar, Jonathan Koffman

PLOS ONE (2020)

Article Multidisciplinary Sciences

Impact of advance care planning on dying in hospital: Evidence from urgent care records

Martina Orlovic, Tom Callender, Julia Riley, Ara Darzi, Joanne Droney

PLOS ONE (2020)

Article Health Care Sciences & Services

Healthcare use and costs in the last year of life: a national population data linkage study

Katharina Diernberger, Xhyljeta Luta, Joanna Bowden, Marie Fallon, Joanne Droney, Elizabeth Lemmon, Ewan Gray, Joachim Marti, Peter Hall

Summary: The study found that secondary care use was high in the last year of life, especially with a sharp rise in inpatient admissions in the last 3 months. People dying of cancer had the greatest number of hospital admissions before death, while those with dementia had the least. Older age was associated with lower admission rates and cost, and there was higher resource use in urban areas, with no observed difference by deprivation.

BMJ SUPPORTIVE & PALLIATIVE CARE (2021)

Review Health Care Sciences & Services

Evidence on the economic value of end-of-life and palliative care interventions: a narrative review of reviews

Xhyljeta Luta, Baptiste Ottino, Peter Hall, Joanna Bowden, Bee Wee, Joanne Droney, Julia Riley, Joachim Marti

Summary: The analysis of 43 reviews shows that most evidence on cost-effectiveness relates to home-based interventions, which offer substantial savings to the health system. Evidence on interventions delivered across other settings was generally inconsistent. Some palliative care models may contribute to a dual improvement in quality of care by lowering aggressive medicalization rates in the last phase of life accompanied by a reduction in costs.

BMC PALLIATIVE CARE (2021)

Article Oncology

care for patients around the time of haematopoietic stem cell transplant: a qualitative study of patients' perceptions and experiences of unmet need and attitudes towards palliative care involvement

Rebecca Gemmell, Angela Halley, Anna-Marie Stevens, Alison Allam, Margaret Perkins, Mark Ethell, Priya Sriskandarajah, Joanne Droney

Summary: This study highlights the potential benefits of early palliative care for patients prior to stem cell transplant, improving quality of life and supporting shared decision-making. Patients often associate palliative care with end-of-life care, but are open to the service once its purpose is explained to them.

SUPPORTIVE CARE IN CANCER (2022)

Article Oncology

Integrated palliative care: triggers for referral to palliative care in ICU patients

Yashna Nadkarni, Ivana Kukec, Pascale Gruber, Shaman Jhanji, Joanne Droney

Summary: Palliative care within ICU is beneficial for decision-making, symptom control, and end-of-life care. Trigger tools can help identify the need for palliative care referral during ICU admission, with the majority of patients warranting referral either before or during admission.

SUPPORTIVE CARE IN CANCER (2022)

Article Health Care Sciences & Services

End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19

Philippa McFarlane, Angela Halley, Yukie Kano, Nicola Wade, Sophie Wilson, Joanne Droney

Summary: Despite abundant research on COVID-19, there is a lack of evidence regarding the specific needs and experiences of cancer patients at the end-of-life stage. This study retrospectively describes the care provided to 34 hospitalized cancer patients who died from COVID-19. The study evaluates the main aspects of end-of-life care, including pain and symptom management, communication and decision-making, and the involvement of the palliative care team. While physical symptoms were managed adequately, the study highlights the high levels of anxiety among patients and their families, indicating the complexity of dealing with a stigmatized disease. The findings emphasize the importance of recognizing the vulnerability of advanced cancer patients with COVID-19 and the need for proactive symptom management, anticipatory communication, and adequate family support.

JOURNAL OF PATIENT EXPERIENCE (2022)

Article Oncology

Intensity of care in cancer patients in the last year of life: a retrospective data linkage study

Xhyljeta Luta, Katharina Diernberger, Joanna Bowden, Joanne Droney, Peter Hall, Joachim Marti

Summary: Delivering high-quality palliative and end-of-life care for cancer patients is a major challenge. This study examines the intensity and costs of cancer care in the last year of life in England. The findings reveal that healthcare utilization and costs increase significantly in the last month of life, with hospital costs being the largest. Age, comorbidity burden, type of cancer, and geographical location were all found to affect the costs. The unclear value of healthcare in the last year of life for advanced cancer patients highlights the need for further research to determine the most appropriate models of care.

BRITISH JOURNAL OF CANCER (2022)

Article Health Care Sciences & Services

Cancer centre supportive oncology service: health economic evaluation

Eleanor Stewart, Simon Tavabie, Caroline McGovern, Alex Round, Laura Shaw, Stephen BAss, Rob Herriott, Emily Savage, Katie Young, Andrea Bruun, Joanne Droney, Daniel Monnery, Geoffrey Wells, Nicola White, Ollie Minton

Summary: The study described a multidisciplinary service for treatable but not curable cancer patients at University Hospitals Sussex, showing a reduction in length of stay and readmission rates. Despite slightly higher costs, there was a clear return on investment with a benefit cost ratio of 1.4.

BMJ SUPPORTIVE & PALLIATIVE CARE (2023)

Article Oncology

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Annika Fendler, Lewis Au, Scott T. C. Shepherd, Fiona Byrne, Maddalena Cerrone, Laura Amanda Boos, Karolina Rzeniewicz, William Gordon, Benjamin Shum, Camille L. Gerard, Barry Ward, Wenyi Xie, Andreas M. Schmitt, Nalinie Joharatnam-Hogan, Georgina H. Cornish, Martin Pule, Leila Mekkaoui, Kevin W. Ng, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, Sarah Sarker, Karla Lingard, Mary Mangwende, Lucy Holt, Hamid Ahmod, Richard Stone, Camila Gomes, Helen R. Flynn, Ana Agua-Doce, Philip Hobson, Simon Caidan, Michael Howell, Mary Wu, Robert Goldstone, Margaret Crawford, Laura Cubitt, Harshil Patel, Mike Gavrielides, Emma Nye, Ambrosius P. Snijders, James MacRae, Jerome Nicod, Firza Gronthoud, Robyn L. Shea, Christina Messiou, David Cunningham, Ian Chau, Naureen Starling, Nicholas Turner, Liam Welsh, Nicholas van As, Robin L. Jones, Joanne Droney, Susana Banerjee, Kate C. Tatham, Shaman Jhanji, Mary O'Brien, Olivia Curtis, Kevin Harrington, Shreerang Bhide, Jessica Bazin, Anna Robinson, Clemency Stephenson, Tim Slattery, Yasir Khan, Zayd Tippu, Isla Leslie, Spyridon Gennatas, Alicia Okines, Alison Reid, Kate Young, Andrew J. S. Furness, Lisa Pickering, Sonia Gandhi, Steve Gamblin, Charles Swanton, Emma Nicholson, Sacheen Kumar, Nadia Yousaf, Katalin A. Wilkinson, Anthony Swerdlow, Ruth Harvey, George Kassiotis, James Larkin, Robert J. Wilkinson, Samra Turajlic

Summary: Patients with cancer have higher morbidity and mortality when infected with COVID-19. The CAPTURE study found that while most patients had immune responses against the original SARS-CoV-2, neutralizing antibody titers against variants were significantly reduced, with some patients experiencing a decrease in antibody levels. However, neutralizing antibody titers remained stable for some patients.

NATURE CANCER (2021)

Article Oncology

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Annika Fendler, Scott T. C. Shepherd, Lewis Au, Katalin A. Wilkinson, Mary Wu, Fiona Byrne, Maddalena Cerrone, Andreas M. Schmitt, Nalinie Joharatnam-Hogan, Benjamin Shum, Zayd Tippu, Karolina Rzeniewicz, Laura Amanda Boos, Ruth Harvey, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, Sarah Sarker, Karla Lingard, Mary Mangwende, Lucy Holt, Hamid Ahmod, Justine Korteweg, Tara Foley, Jessica Bazin, William Gordon, Taja Barber, Andrea Emslie-Henry, Wenyi Xie, Camille L. Gerard, Daqi Deng, Emma C. Wall, Ana Agua-Doce, Sina Namjou, Simon Caidan, Mike Gavrielides, James MacRae, Gavin Kelly, Kema Peat, Denise Kelly, Aida Murra, Kayleigh Kelly, Molly O'Flaherty, Lauren Dowdie, Natalie Ash, Firza Gronthoud, Robyn L. Shea, Gail Gardner, Darren Murray, Fiona Kinnaird, Wanyuan Cui, Javier Pascual, Simon Rodney, Justin Mencel, Olivia Curtis, Clemency Stephenson, Anna Robinson, Bhavna Oza, Sheima Farag, Isla Leslie, Aljosja Rogiers, Sunil Iyengar, Mark Ethell, Christina Messiou, David Cunningham, Ian Chau, Naureen Starling, Nicholas Turner, Liam Welsh, Nicholas van As, Robin L. Jones, Joanne Droney, Susana Banerjee, Kate C. Tatham, Mary O'Brien, Kevin Harrington, Shreerang Bhide, Alicia Okines, Alison Reid, Kate Young, Andrew J. S. Furness, Lisa Pickering, Charles Swanton, Sonia Gandhi, Steve Gamblin, David L. Bauer, George Kassiotis, Sacheen Kumar, Nadia Yousaf, Shaman Jhanji, Emma Nicholson, Michael Howell, Susanna Walker, Robert J. Wilkinson, James Larkin, Samra Turajlic

Summary: A cohort study evaluated 585 cancer patients following vaccination with BNT162b2 or AZD1222 vaccines, finding lower antibody responses in patients with hematological malignancies compared to those with solid tumors. Patients with hematological malignancies also had reduced neutralizing antibody responses compared to individuals without cancer. The study highlights the importance of managing cancer patients during the ongoing COVID-19 pandemic.

NATURE CANCER (2021)

No Data Available